These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 130981)

  • 1. [Effects of intradermally administered tularin Sevac on the titre of slow agglutination reaction with the Francisella tularensis antigen (author's transl)].
    Cerný Z
    Cesk Epidemiol Mikrobiol Imunol; 1975 Nov; 24(6):337-43. PubMed ID: 130981
    [No Abstract]   [Full Text] [Related]  

  • 2. [The presence of antibodies against Francisella tularensis among inhabitants of North-Eastern Poland].
    Hermanowska-Szpakowicz T; Pancewicz SA
    Przegl Epidemiol; 1996; 50(1-2):55-9. PubMed ID: 8711161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rapid processing of material for the antibody neutralization test in case of detection of antigen of tularemia and F-1 plague].
    Dobrokhotov BP; Meshcheriakova IS
    Lab Delo; 1974; 7(9):440. PubMed ID: 4214964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Should ticks be regarded as a tularemia vector in habitants of North-Eastern Poland?].
    Pancewicz SA; Zajkowska JM; Swierzbińska R; Kondrusik M; Grygorczuk SS; Hermanowska-Szpakowicz T
    Med Pr; 2004; 55(2):189-92. PubMed ID: 15524088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bubonic tularemia: diagnosis and therapy].
    Iushchuk ND; Ostrovskiĭ NN; Karetkina GN; Ogienko OL; Timchenko OL; Mitrikova LTs; Kulagina MV; Bakulina ZE; Safonova OA; Tlatova IS; Lapina TS; Popova TI; Tsvetkova NA; Burchik MA
    Ter Arkh; 2008; 80(4):51-4. PubMed ID: 18491581
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of a serological micromethod for the detection of antibodies against Francisella tularensis].
    Nunes MP; Ricciardi ID
    An Microbiol (Rio J); 1980; 25():61-7. PubMed ID: 6982628
    [No Abstract]   [Full Text] [Related]  

  • 8. The laboratory diagnosis of tularemia.
    Brown M
    Va Med Mon (1918); 1970 Jun; 97(6):388-90. PubMed ID: 5528117
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevalence of antibodies against Francisella tularensis in Castilla y León (Spain) before 1997].
    Gutiérrez MP; Orduña A; Dueñas A; Bratos MA; Almaraz A; Alamo R; Rodríguez Recio MJ; Rodríguez Marcos H; Rodríguez Torres A
    Med Clin (Barc); 2003 Feb; 120(3):97-8. PubMed ID: 12605730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
    Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
    Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tularemia laboratory infection].
    Kruczalowa M; Zieliński A; Ziemichód T
    Przegl Epidemiol; 1974; 28(4):567-9. PubMed ID: 4445529
    [No Abstract]   [Full Text] [Related]  

  • 12. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
    Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
    J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of antibodies to Francisella tularensis in cats.
    Magnarelli L; Levy S; Koski R
    Res Vet Sci; 2007 Feb; 82(1):22-6. PubMed ID: 16914176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the enzyme-linked immunosorbent assay for the serodiagnosis of tularemia].
    Rastawicki W; Jagielski M; Gierczyński R
    Med Dosw Mikrobiol; 2005; 57(4):425-9. PubMed ID: 16773836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human serum and nasal hemagglutinating antibody to Francisella tularensis.
    Bellanti JA; Buescher EL; Brandt WE; Dangerfield HG; Crozier D
    J Immunol; 1967 Jan; 98(1):171-8. PubMed ID: 4163639
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity.
    Raynaud C; Meibom KL; Lety MA; Dubail I; Candela T; Frapy E; Charbit A
    Infect Immun; 2007 Jan; 75(1):536-41. PubMed ID: 17030571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Examination of a natural tularemia focus in the Crimea using a passive hemagglutination reaction system].
    Golkovskiĭ GM; Shikulov VA; Korchevskiĭ PG; Korchevskaia VA; Teremenko LA
    Vrach Delo; 1980 Jan; (1):109-11. PubMed ID: 6445649
    [No Abstract]   [Full Text] [Related]  

  • 18. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of tularemia seroprevalence in the rural area of Thrace region in Turkey].
    Dedeoğlu Kilinç G; Gürcan S; Eskiocak M; Kiliç H; Kunduracilar H
    Mikrobiyol Bul; 2007 Jul; 41(3):411-8. PubMed ID: 17933252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence study of Francisella tularensis among hunters in Germany.
    Jenzora A; Jansen A; Ranisch H; Lierz M; Wichmann O; Grunow R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):183-9. PubMed ID: 18462387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.